Bicycle Therapeutics

Bicycle Therapeutics and Pepscan Enter Into Partnership to Apply Constrained Peptide Technology in the Development of Novel Biotherapeutics

Bicycle Therapeutics Ltd, a New Medical Research Council (MRC) Spin-out, Seeking to Merge Best Aspects of Small Molecules and Biologics, Secures Seed Funding From Top Venture Capital Firms

CAMBRIDGE, England and LELYSTAD, The Netherlands - Bicycle Therapeutics has obtained a global license from Pepscan to utilize its proprietary constrained peptide chemistry technology.

MORE..

Older News

LONDON - Bicycle Therapeutics Ltd, a new biotechnology company developing a novel technology platform for the creation of a new generation of biotherapeutics, has secured seed funding from Atlas Venture and Novartis Venture Fund.

MORE..